Bile salt export pump: A sensitive and specific immunohistochemical marker of hepatocellular carcinoma

Histopathology

Volumn 66, Issue 4, 2015, Pages 598-602

  Lagana, Stephen M ^a   Salomao, Marcela ^a   Remotti, Helen E ^a   Knisely, A S ^b   Moreira, Roger K ^c  

^a Department of Medicine   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

Bile salt export pump; Hepatocellular carcinoma; Immunohistochemistry

Indexed keywords

ARGINASE 1; BILE SALT EXPORT PUMP; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CD103 ANTIGEN; GLYPICAN 3; HEPATOCYTE PARAFFIN 1 ANTIGEN; PROTEIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCB11 PROTEIN, HUMAN; TUMOR MARKER;

ADRENAL GLAND; ADRENAL TUMOR; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER CELL CARCINOMA; LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; AGED; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; LIVER NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84922800404     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12601     Document Type: Article

References (19)

1. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am. J. Pathol. 1993; 143; 1050-1054.
2. Xiao SY, Wang HL, Hart J, Fleming D, Beard MR. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am. J. Pathol. 2001; 159; 1415-1421.
3. Yan BC, Gong C, Song J et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am. J. Surg. Pathol. 2010; 34; 1147-1154.
4. Capurro M, Wanless IR, Sherman M et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125; 89-97.
5. Zhang L, Liu H, Sun L, Li N, Ding H, Zheng J. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Acta Histochem. 2012; 114; 547-552.
6. Lagana SM, Moreira RK, Remotti HE, Bao F. Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver. Appl. Immunohistochem. Mol. Morphol. 2013; 21; 254-257.
7. The Human Protein Atlas [internet]. 2014 (cited 15 August 2014). Available at: http://www.proteinatlas.org/ENSG00000073734/tissue.
8. Strautnieks SS, Bull LN, Knisely AS et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998; 20; 233-238.
9. Knisely A. Hepatocellular carcinoma, renal cell carcinoma metastatic to liver, and adrenal carcinoma metastatic to liver: immunostaining for bile salt export pump as a marker of hepatocellular differentiation. Lab. Invest. 2009; 89(Suppl. 1); 312A-313A.
10. Edmondson HASP. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 1954; 7; 462-503.
11. Butler SL, Dong H, Cardona D et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab. Invest. 2008; 88; 78-88.
12. Gulluoglu MG, Karayigit E, Ozden I, Kapran Y, Dizdaroglu F. Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer? Pathology 2008; 40; 35-41.
13. Fan Z, Li J, Dong B, Huang X. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Clin. Cancer Res. 2005; 11; 6162-6170.
14. Mac MT, Chung F, Lin F, Hui P, Balzer BL, Wang HL. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. Am. J. Clin. Pathol. 2009; 132; 80-85.
15. Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3, 940 tissue samples. Am. J. Clin. Pathol. 2004; 122; 721-727.
16. Radwan NA, Ahmed NS. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Diagn. Pathol. 2012; 7; 149.
17. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999; 230; 309-318; discussion 18-21.
18. Musunuru S, Chen H, Rajpal S et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch. Surg. 2006; 141; 1000-1004; discussion 5.
19. Lagana SM, Hsiao S, Bao F et al. HepPar-1 and arginase-1 in small intestinal and ampullary adenocarcinoma. Virchows Arch. 2013; 463; 148-149.